Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

Clinical trial NCT01426230 · COMPLETED

Trial details

NCT number: NCT01426230
Sponsor: Depomed
Status: COMPLETED
Study type: OBSERVATIONAL

Post Herpetic Neuralgia

Start date: 2011-09-01
Primary completion: 2012-03-01
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.